Pancreatic Cancer Research

ResearcherFoundation Medicine (United States)No recent work listed

Ethan S. Sokol

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5480-8473; OpenAlex author ID A5067701996. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer. Last author DOI 10.1093/oncolo/oyad178↗
  2. Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism. Co-author DOI 10.1038/s41388-022-02184-2↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie He · 1 shared paper, 2023 · strength 0.15
  2. Kuei‐Ting Chen · 1 shared paper, 2023 · strength 0.15
  3. Michael Jon Pishvaian · 1 shared paper, 2023 · strength 0.15
  4. Aatur Dilip Singhi · 1 shared paper, 2023 · strength 0.15
  5. Shani Journo · 1 shared paper, 2022 · strength 0.15
  6. Ido Wolf · 1 shared paper, 2022 · strength 0.15
  7. Tamar Rubinek · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.